$49 Profit
CASCLong Stock
Biotech - Cascadian Therapeutics (CASC) Catalyst Dates: Phase 1b updated metastatic breast cancer data due out December 5-9 at the SABCS conference.-----bought a small position & scalped when the price popped up
| Date | Price | |
|---|---|---|
| Entry | 11/20/2017 | 4.1066 |
| Exit | 11/23/2017 | 4.1714 |
- Total Views166
- Position Size750
- Percentage1.58%
Copy and paste the following into your page or blog. If using WordPress, you must paste this in the HTML tab only:
